Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD
Clinical trial NCT05181995 · TERMINATED
Trial details
- NCT number
- NCT05181995
- Sponsor
- Aptinyx
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-13
- Primary completion
- 2023-03-30
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.